Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24307650 | 0.67 | NOS2 (0.34) | — | |
| SCHEMBL5707043 | 0.65 | — | — | |
| SCHEMBL5707055 | 0.65 | NOS1 (0.34) | — | |
| SCHEMBL708993 | 0.64 | KDM1A (0.31) | KDM1A | |
| SCHEMBL7751743 | 0.63 | KDM1A (0.30) | KDM1A | |
| SCHEMBL24307625 | 0.63 | NOS1 (0.33) | — | |
| SCHEMBL24307459 | 0.63 | NOS1 (0.32) | — | |
| SCHEMBL7622328 | 0.62 | KDM1A (0.40) | KDM1A | |
| SCHEMBL7090933 | 0.62 | TLR4 (0.37) | KDM1A | |
| SCHEMBL526778 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12516019-B2 | Amphoteric compounds | EASTMAN CHEMICAL COMPANY (US) | 2026-01-06 | — | — | US | claimed |
| US-20220356151-A1 | AMPHOTERIC COMPOUNDS | EASTMAN CHEMICAL COMPANY (US) | 2022-11-10 | — | — | US | claimed |
| US-11414380-B2 | Amphoteric compounds | EASTMAN CHEMICAL COMPANY (US) | 2022-08-16 | — | — | US | claimed |
| CN-114671788-A | Amphoteric ester sulfonate | 伊士曼化工公司 | 2022-06-28 | — | — | CN | claimed |
| EP-3209645-B1 | AMPHOTERIC ESTER SULFONATES | EASTMAN CHEM CO (US) | 2021-09-15 | — | — | EP | claimed |
| EP-3350160-B1 | MIXTURES OF AMPHOTERIC BETAINE COMPOUNDS AND AN ENZYMIC PROCESS FOR THEIR PRODUCTION | EASTMAN CHEM CO (US) | 2021-05-26 | — | — | EP | claimed |
| CN-108774170-B | Octahydroacridine skeleton with three continuous chiral centers and preparation method thereof | 中南大学 | 2021-05-14 | — | — | CN | claimed |
| CN-111423344-A | Amphoteric ester sulfonate | 伊士曼化工公司 | 2020-07-17 | — | — | CN | claimed |
| EP-3350160-A1 | AMPHOTERIC BETAINE COMPOUNDS | Eastman Chemical Company (US) | 2018-07-25 | — | — | EP | claimed |
| US-20180185801-A1 | AMPHOTERIC ESTER SULFONATES | EASTMAN CHEMICAL COMPANY (US) | 2018-07-05 | — | — | US | claimed |
| US-20150376516-A1 | Method and Compositions for Inhibition of Naphthenic Acid Induced Corrosion | BAKER HUGHES INCORPORATED (US) | 2015-12-31 | — | — | US | claimed |
| US-20150011749-A1 | USE OF CERTAIN METAL-ACCUMULATING PLANTS FOR THE PERFORMANCE OF ORGANIC CHEMISTRY REACTIONS | UNIVERSITE MONTPELLIER 2 SCIENCES ET TECHNIQUES (FR) | 2015-01-08 | — | — | US | claimed |
| EP-2046918-A1 | METHOD AND COMPOSITIONS FOR INHIBITION OF NAPHTHENIC ACID INDUCED CORROSION | Baker Hughes Incorporated (US) | 2009-04-15 | — | — | EP | claimed |
| WO-2008005058-A1 | METHOD AND COMPOSITIONS FOR INHIBITION OF NAPHTHENIC ACID INDUCED CORROSION | BAKER HUGHES INCORPORATED (US) | 2008-01-10 | — | — | WO | claimed |
| US-20080001125-A1 | Method and compositions for inhibition of naphthenic acid induced corrosion | BAKER HUGHES INCORPORATED (US) | 2008-01-03 | — | — | US | claimed |
| CN-1239486-C | Acridine derivative and its application | CHANGCHUN HUAYANG HIGH TECH CO (CN) | 2006-02-01 | — | — | CN | claimed |
| CN-1523016-A | Acridine derivative and its application | 长春华洋高科技有限公司 | 2004-08-25 | — | — | CN | claimed |
| EP-0077353-A1 | 1-HYDROXYLATION PROCESS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1983-04-27 | — | — | EP | claimed |
| WO-1982003864-A1 | 1-HYDROXYLATION PROCESS | WISCONSIN ALUMNI RES FOUND (US) | 1982-11-11 | — | — | WO | claimed |
| US-4338250-A | 1-Hydroxylation process | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1982-07-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11414380-B2 | Amphoteric compounds | S100A4, S100A6, ANXA4 | KDM1A 2283/4885 |
| US-20150011749-A1 | USE OF CERTAIN METAL-ACCUMULATING PLANTS FOR THE PERFORMANCE OF ORGANIC CHEMISTRY REACTIONS | ME1, OSGEP, AGL | KDM1A 2855/4885 |
| US-20220356151-A1 | AMPHOTERIC COMPOUNDS | S100A4, S100A6, ANXA4 | KDM1A 2283/4885 |
| US-20180185801-A1 | AMPHOTERIC ESTER SULFONATES | ACMSD, SGMS1, SGMS2 | KDM1A 2395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.